CUE BIOPHARMA INC. - COMMON STOCK

Cue Biopharma to Present Corporate Overview and Clinical Progress at the Upcoming Oppenheimer 31st Annual Healthcare Conference

15 мар 2021 08:00:01 Источник Nasdaq GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

09 мар 2021 08:00:00 Источник Nasdaq GlobeNewswire

Cue Biopharma to Present at the Cowen 41st Annual Health Care Conference

01 мар 2021 08:00:01 Источник Nasdaq GlobeNewswire

Cue Biopharma Enhances Scientific Advisory Board with Appointments of Immunology and Immunotherapy Experts Dr. Abul K. Abbas and Dr. Michael Kalos

25 фев 2021 08:00:01 Источник Nasdaq GlobeNewswire

Cue Biopharma Announces Appointment of Matteo Levisetti, M.D. as Senior Vice President of Clinical Development

17 фев 2021 08:00:01 Источник Nasdaq GlobeNewswire

Cue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 in Combination with KEYTRUDA® (pembrolizumab) as First-line Treatment for HPV+ Recurrent/Metastatic Head and Neck Cancer

08 фев 2021 08:00:01 Источник Nasdaq GlobeNewswire